Myos Corp. to present mode of action data on Fortetropin myostatin inhibitor
MYOS Corporation, developers of muscle-health ingredient Fortetropin, have announced new data elucidating the ingredient’s mode of action that will be presented at a scientific conference in Boston. The new data shows the ingredient works in three...